We are live on ! Find out more
FG

Formula Growth Portfolio holdings

AUM $284M
1-Year Est. Return 54.56%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+54.56%
3 Year Est. Return
+117.67%
5 Year Est. Return
+78.26%
10 Year Est. Return
+276.27%
AUM
$725M
AUM Growth
+$30.2M
Cap. Flow
-$13M
Cap. Flow %
-1.8%
Top 10 Hldgs %
27.82%
Holding
177
New
13
Increased
38
Reduced
24
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 34.04%
2 Consumer Discretionary 19.82%
3 Healthcare 13.63%
4 Communication Services 12.41%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAE
176
DELISTED
PAE Incorporated Class A Common Stock
PAE
-580,745
Closed -$5.24M
CLDR
177
DELISTED
Cloudera, Inc.
CLDR
-874,245
Closed -$10.6M

Similar funds

Formula Growth's Q2 2021 Portfolio in Review

As of Q2 2021, Formula Growth held 177 positions worth $725M, up 4.4% from $695M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Formula Growth's Q2 2021 filing shows 13 new, 38 increased, 24 reduced and 30 closed positions. Its largest new stake was Progyny: 125,000 shares worth $7.38M. The largest sale was Nuance Communications, Inc., an estimated $21.6M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Formula Growth's largest Q2 2021 buy was Progyny: 125,000 shares worth $7.38M.
  • Formula Growth added most to Paramount Global Class B in Q2 2021, an estimated $16.1M increase.
  • Formula Growth's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $12.9M.
  • Formula Growth fully exited Nuance Communications, Inc. in Q2 2021, selling an estimated $21.6M.
  • Formula Growth's ten largest holdings make up 28% of its $725M portfolio in Q2 2021.
  • Formula Growth opened 13 new positions and closed 30 in Q2 2021.
  • Formula Growth's portfolio value rose 4.4% quarter-over-quarter to $725M.

Based on Formula Growth's 13F filing for Q2 2021, filed 13 Aug 2021.